Health In Tech, Inc. Class A Common Stock (HIT)vsNVIDIA Corporation (NVDA)
HIT
Health In Tech, Inc. Class A Common Stock
$1.45
0.00%
TECHNOLOGY · Cap: $98.29M
NVDA
NVIDIA Corporation
$199.57
-4.63%
TECHNOLOGY · Cap: $5.09T
Smart Verdict
WallStSmart Research — data-driven comparison
NVIDIA Corporation generates 647827% more annual revenue ($215.94B vs $33.33M). NVDA leads profitability with a 55.6% profit margin vs 3.8%. NVDA trades at a lower P/E of 42.7x. NVDA earns a higher WallStSmart Score of 79/100 (B+).
HIT
Avoid35
out of 100
Grade: F
NVDA
Strong Buy79
out of 100
Grade: B+
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+62.4%
Fair Value
$2.87
Current Price
$1.45
$1.42 discount
Intrinsic value data unavailable for NVDA.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 53.1% year-over-year
Mega-cap, among the largest globally
Every $100 of equity generates 102 in profit
Keeps 56 of every $100 in revenue as profit
Strong operational efficiency at 65.0%
Revenue surging 73.2% year-over-year
Earnings expanding 95.6% YoY
Areas to Watch
Smaller company, higher risk/reward
3.8% margin — thin
Premium valuation, high expectations priced in
Negative free cash flow — burning cash
Weak financial health signals
Premium valuation, high expectations priced in
Trading at 30.8x book value
Comparative Analysis Report
WallStSmart ResearchBull Case : HIT
The strongest argument for HIT centers on Revenue Growth. Revenue growth of 53.1% demonstrates continued momentum.
Bull Case : NVDA
The strongest argument for NVDA centers on Market Cap, Return on Equity, Profit Margin. Profitability is solid with margins at 55.6% and operating margin at 65.0%. Revenue growth of 73.2% demonstrates continued momentum.
Bear Case : HIT
The primary concerns for HIT are Market Cap, Profit Margin, P/E Ratio. A P/E of 75.0x leaves little room for execution misses. Thin 3.8% margins leave little buffer for downturns.
Bear Case : NVDA
The primary concerns for NVDA are Piotroski F-Score, P/E Ratio, Price/Book. A P/E of 42.7x leaves little room for execution misses.
Key Dynamics to Monitor
HIT profiles as a hypergrowth stock while NVDA is a growth play — different risk/reward profiles.
NVDA is growing revenue faster at 73.2% — sustainability is the question.
NVDA generates stronger free cash flow (34.9B), providing more financial flexibility.
Monitor SOFTWARE - APPLICATION industry trends, competitive dynamics, and regulatory changes.
Bottom Line
NVDA scores higher overall (79/100 vs 35/100), backed by strong 55.6% margins and 73.2% revenue growth. HIT offers better value entry with a 62.4% margin of safety. Both earn "Strong Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Health In Tech, Inc. Class A Common Stock
TECHNOLOGY · SOFTWARE - APPLICATION · USA
Health In Tech, Inc. (HIT) is at the forefront of the digital health revolution, dedicated to enhancing healthcare delivery through innovative technology solutions. By harnessing advanced data analytics and proprietary software, HIT empowers healthcare providers and patients to make informed decisions, resulting in improved patient outcomes and operational efficiencies. The company's robust focus on compliance and cybersecurity uniquely positions it to thrive in the rapidly expanding digital health market. As the industry continues to evolve, HIT is poised to establish itself as a key player in advancing technology-driven healthcare solutions globally.
NVIDIA Corporation
TECHNOLOGY · SEMICONDUCTORS · USA
Nvidia Corporation is an American multinational technology company incorporated in Delaware and based in Santa Clara, California. It designs graphics processing units (GPUs) for the gaming and professional markets, as well as system on a chip units (SoCs) for the mobile computing and automotive market.
Visit Website →Compare with Other SOFTWARE - APPLICATION Stocks
Want to dig deeper into these stocks?